Basak Doganavsargil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Basak Doganavsargil has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Murat Sezak
Department of Medical Pathology, Ege University, 35100 İzmir, Turkey
10 shared publications - Nalan Gülşen Ünal
Department of Gastroenterology, Ege University, İzmir, Türkiye
7 shared publications - Ahmet Ömer Özütemi̇z
Department of Internal Medicine, Division of Gastroenterology, Ege University Faculty of Medicine, Izmir 35040, Turkey
5 shared publications Fikri Oztop
Ege University Faculty of Medicine, Department of Pathology, İzmir, Turkey
5 shared publicationsMurat Sezak
Ege University Faculty of Medicine, Department of Pathology, İzmir, Turkey
5 shared publications- Ayfer Haydaroğlu
Ege Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı, İzmir
4 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Xia & He Publishing in Journal of Clinical and Translational Pathology
- No. 000
Biliary Duct Invasion in Colorectal Liver Metastases: Prevalence and Clinicopathologic Correlation in a Retrospective Cohort Study
Biliary duct invasion (BDI) is an underrecognized growth pattern of colorectal cancer (CRC) liver metastases that can mimic intrahepatic cholangiocarcinoma or intraductal papillary neoplasm of the bile duct. Its prevalence and clinicopathologic associations remain unclear. This study aimed to determine the prevalence of BDI and its clinicopathologic associations in surgically resected CRC liver metastases.
- 16 September 2026
- Published by Xia & He Publishing in Journal of Clinical and Translational Pathology
- No. 000
Open AccessBiliary Duct Invasion in Colorectal Liver Metastases: Prevalence and Clinicopathologic Correlation in a Retrospective Cohort Study
Biliary duct invasion (BDI) is an underrecognized growth pattern of colorectal cancer (CRC) liver metastases that can mimic intrahepatic cholangiocarcinoma or intraductal papillary neoplasm of the bile duct. Its prevalence and clinicopathologic associations remain unclear. This study aimed to determine the prevalence of BDI and its clinicopathologic associations in surgically resected CRC liver metastases.
- Open Access
- 21 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3979
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study
Background: Human epidermal growth factor receptor 2 (HER2) alterations have been implicated as mechanisms of resistance to anti-epidermal growth factor receptor (anti-EGFR) therapy in metastatic colorectal cancer (mCRC). We aimed to evaluate the predictive and prognostic significance of HER2 expression in patients with RAS wild-type mCRC in a real-world setting. Methods: We conducted a multicenter retrospective cohort study across ten oncology centers in Turkey, including patients with RAS wild-type mCRC treated between 2015 and 2022. Clinical outcomes, including progression-free survival (PFS) and overall survival (OS), were compared between HER2-positive and HER2-negative groups. Multivariable Cox proportional hazards models were used to identify independent predictors of survival outcomes. Results: Among 204 patients, 28 (13.7%) were HER2-positive. Baseline characteristics were generally comparable; however, HER2-positive patients showed a trend toward higher-grade tumors and were significantly less likely to receive anti-EGFR therapy. HER2-positive patients had significantly shorter PFS compared to HER2-negative patients (median 10 vs. 13 months; p = 0.006). In multivariable analysis, HER2 positivity remained an independent predictor of shorter PFS (HR 1.76, 95% CI 1.01–3.07; p = 0.045). In the subgroup of 144 patients receiving anti-EGFR therapy, HER2-positive patients also demonstrated significantly shorter PFS (median 9.0 vs. 14.0 months; p = 0.023). No significant differences in OS were observed between groups. Conclusions: HER2 positivity is associated with reduced response to anti-EGFR therapy and independently predicts shorter PFS in patients with RAS wild-type mCRC. These findings further support the role of HER2 as a clinically relevant biomarker in RAS wild-type mCRC, particularly in predicting response to anti-EGFR therapy, while highlighting the need for optimized patient selection strategies in the era of HER2-targeted treatments.
- 21 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3979
Open AccessPrognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study
Background: Human epidermal growth factor receptor 2 (HER2) alterations have been implicated as mechanisms of resistance to anti-epidermal growth factor receptor (anti-EGFR) therapy in metastatic colorectal cancer (mCRC). We aimed to evaluate the predictive and prognostic significance of HER2 expression in patients with RAS wild-type mCRC in a real-world setting. Methods: We conducted a multicenter retrospective cohort study across ten oncology centers in Turkey, including patients with RAS wild-type mCRC treated between 2015 and 2022. Clinical outcomes, including progression-free survival (PFS) and overall survival (OS), were compared between HER2-positive and HER2-negative groups. Multivariable Cox proportional hazards models were used to identify independent predictors of survival outcomes. Results: Among 204 patients, 28 (13.7%) were HER2-positive. Baseline characteristics were generally comparable; however, HER2-positive patients showed a trend toward higher-grade tumors and were significantly less likely to receive anti-EGFR therapy. HER2-positive patients had significantly shorter PFS compared to HER2-negative patients (median 10 vs. 13 months; p = 0.006). In multivariable analysis, HER2 positivity remained an independent predictor of shorter PFS (HR 1.76, 95% CI 1.01–3.07; p = 0.045). In the subgroup of 144 patients receiving anti-EGFR therapy, HER2-positive patients also demonstrated significantly shorter PFS (median 9.0 vs. 14.0 months; p = 0.023). No significant differences in OS were observed between groups. Conclusions: HER2 positivity is associated with reduced response to anti-EGFR therapy and independently predicts shorter PFS in patients with RAS wild-type mCRC. These findings further support the role of HER2 as a clinically relevant biomarker in RAS wild-type mCRC, particularly in predicting response to anti-EGFR therapy, while highlighting the need for optimized patient selection strategies in the era of HER2-targeted treatments.
- Open Access
- 19 December 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (2) , 127-130
Hydatic Cyst Infection of the Tibia Mimicking Chondrosarcoma on 18F-FDG PET/CT Scan
Hydatic Cyst Infection of the Tibia Mimicking Chondrosarcoma on 18F-FDG PET/CT Scan - Molecular Imaging and Radionuclide Therapy
- 19 December 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (2) , 127-130
Open AccessHydatic Cyst Infection of the Tibia Mimicking Chondrosarcoma on 18F-FDG PET/CT Scan
Hydatic Cyst Infection of the Tibia Mimicking Chondrosarcoma on 18F-FDG PET/CT Scan - Molecular Imaging and Radionuclide Therapy
- Open Access
- 22 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 2962
Clinicopathologic Determinants of Lymph Node Count and Prognostic Significance of Metastatic Lymph Node Ratio in Colorectal Cancer
Background/Objectives: Accurate lymph node (LN) evaluation is crucial to predicting outcomes in colorectal cancer (CRC). Higher lymph node counts (LNCs) improve prognosis, whereas increased metastatic involvement worsens survival. This study aimed to identify factors associated with higher LNCs and evaluate the prognostic value of the metastatic lymph node ratio (MLNR). Methods: A retrospective analysis was performed on 989 CRC resections. Patients were stratified into four MLNR categories—MLNR0 (no metastasis), MLNR1 (0.50)—and into two LNC groups—lower LNC (p < 0.001), larger tumor size (p < 0.001), higher pN stage (p < 0.001), right-sided location (p = 0.003), Crohn’s-like lymphocytic response (p = 0.006), and the absence of satellite nodules (p = 0.016). There were 86 pT4 and 178 pN2 tumors. Overall survival was 50.6%, with the 1-, 3-, and 5-year rates being 0.891, 0.721, and 0.612, respectively. Survival was higher in patients with higher LNCs (53.5% vs. 45.1%, p < 0.001). Survival rates by MLNR were 61.2% (MLNR0), 47.7% (MLNR1), 34.0% (MLNR2), and 26.4% (MLNR3). Mortality strongly correlated with MLNR (p < 0.001), and life expectancy decreased as MLNR increased (p < 0.01). Conclusions: MLNR provides superior prognostic information compared to pN status, even in patients with suboptimal lymph node retrieval (LNC < 12). As an independent survival predictor, MLNR may be integrated into staging systems and guide therapeutic strategies, highlighting its clinical utility in both standard and “gray zone” CRC cases.
- 22 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 2962
Open AccessClinicopathologic Determinants of Lymph Node Count and Prognostic Significance of Metastatic Lymph Node Ratio in Colorectal Cancer
Background/Objectives: Accurate lymph node (LN) evaluation is crucial to predicting outcomes in colorectal cancer (CRC). Higher lymph node counts (LNCs) improve prognosis, whereas increased metastatic involvement worsens survival. This study aimed to identify factors associated with higher LNCs and evaluate the prognostic value of the metastatic lymph node ratio (MLNR). Methods: A retrospective analysis was performed on 989 CRC resections. Patients were stratified into four MLNR categories—MLNR0 (no metastasis), MLNR1 (0.50)—and into two LNC groups—lower LNC (p < 0.001), larger tumor size (p < 0.001), higher pN stage (p < 0.001), right-sided location (p = 0.003), Crohn’s-like lymphocytic response (p = 0.006), and the absence of satellite nodules (p = 0.016). There were 86 pT4 and 178 pN2 tumors. Overall survival was 50.6%, with the 1-, 3-, and 5-year rates being 0.891, 0.721, and 0.612, respectively. Survival was higher in patients with higher LNCs (53.5% vs. 45.1%, p < 0.001). Survival rates by MLNR were 61.2% (MLNR0), 47.7% (MLNR1), 34.0% (MLNR2), and 26.4% (MLNR3). Mortality strongly correlated with MLNR (p < 0.001), and life expectancy decreased as MLNR increased (p < 0.01). Conclusions: MLNR provides superior prognostic information compared to pN status, even in patients with suboptimal lymph node retrieval (LNC < 12). As an independent survival predictor, MLNR may be integrated into staging systems and guide therapeutic strategies, highlighting its clinical utility in both standard and “gray zone” CRC cases.
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 5035877
Influence of Fusobacterium nucleatum on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis
Inflammatory bowel disease (IBD), including ulcerative colitis (UC), involves chronic gastrointestinal inflammation, with tumor necrosis factor alpha (TNF‐α) playing a key role. Anti‐TNF therapy is widely used, but not all UC patients respond, suggesting additional contributing factors. Gut microbiota alterations, particularly dysbiosis, may influence treatment outcomes. This study examines the relationship between Fusobacterium nucleatum ( F. nucleatum ) density and TNF‐α expression in UC patients receiving anti‐TNF therapy. Biopsy samples from responders ( n = 10), nonresponders ( n = 10), and healthy controls ( n = 10) were analyzed using real‐time PCR. Fusobacterium nucleatum density was significantly higher in nonresponders than in responders (3.2‐fold, p < 0.05) and controls (fivefold, p < 0.05). TNF‐α expression was elevated in both UC groups. These findings suggest F. nucleatum may contribute to anti‐TNF therapy resistance by modulating intestinal inflammation, highlighting its potential as a biomarker for treatment prediction.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 5035877
Open AccessInfluence of Fusobacterium nucleatum on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis
Inflammatory bowel disease (IBD), including ulcerative colitis (UC), involves chronic gastrointestinal inflammation, with tumor necrosis factor alpha (TNF‐α) playing a key role. Anti‐TNF therapy is widely used, but not all UC patients respond, suggesting additional contributing factors. Gut microbiota alterations, particularly dysbiosis, may influence treatment outcomes. This study examines the relationship between Fusobacterium nucleatum ( F. nucleatum ) density and TNF‐α expression in UC patients receiving anti‐TNF therapy. Biopsy samples from responders ( n = 10), nonresponders ( n = 10), and healthy controls ( n = 10) were analyzed using real‐time PCR. Fusobacterium nucleatum density was significantly higher in nonresponders than in responders (3.2‐fold, p < 0.05) and controls (fivefold, p < 0.05). TNF‐α expression was elevated in both UC groups. These findings suggest F. nucleatum may contribute to anti‐TNF therapy resistance by modulating intestinal inflammation, highlighting its potential as a biomarker for treatment prediction.
- Open Access
- 30 October 2023
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
Revisiting the Role of Esophageal Mucosal Dilated Intercellular Spaces in the Diagnosis and Pathophysiology of Heartburn
Background/Aims Dilated intercellular spaces (DISs) facilitate the diffusion of noxious agents into the deep layers of the esophageal epithelium. The role of DIS in heartburn pathogenesis is still controversial. Therefore, we aim to reinvestigate DIS in an extensively evaluated group of patients and healthy controls (HCs). Methods We classified 149 subjects into the following groups: 15 HC, 58 mild erosive reflux disease (ERD), 17 severe ERD, 25 nonerosive reflux disease (NERD), 15 reflux hypersensitivity (RH), and 19 functional heartburn (FH). A total of 100 length measurements were performed for each patient’s biopsy. Results The overall intercellular spaces (ISs) value of gastroesophageal reflux disease (GERD) patients was higher than that of HC (P = 0.020). In phenotypes, mild ERD (vs HC [P = 0.036], NERD [P = 0.004], RH [P = 0.014]) and severe ERD (vs HC [P = 0.002], NERD [P < 0.001], RH [P = 0.001], FH [P = 0.004]) showed significantly higher IS. There was no significant difference between the HC, NERD, RH, and FH groups. The 1.12 μm DIS cutoff value had 63.5% sensitivity and 66.7% specificity in the diagnosis of GERD. There was a weak correlation (r = 0.302) between the IS value and acid exposure time, and a weak correlation (r = −0.359) between the IS value and baseline impedance. A strong correlation was shown between acid exposure time and baseline impedance (r = −0.783). Conclusions Since the IS length measurement had better discrimination power only in erosive groups, it is not feasible to use in daily routine to discriminate other nonerosive phenotypes and FH. The role of DIS in heartburn in nonerosive patients should be reconsidered.
- 30 October 2023
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
Open AccessRevisiting the Role of Esophageal Mucosal Dilated Intercellular Spaces in the Diagnosis and Pathophysiology of Heartburn
Background/Aims Dilated intercellular spaces (DISs) facilitate the diffusion of noxious agents into the deep layers of the esophageal epithelium. The role of DIS in heartburn pathogenesis is still controversial. Therefore, we aim to reinvestigate DIS in an extensively evaluated group of patients and healthy controls (HCs). Methods We classified 149 subjects into the following groups: 15 HC, 58 mild erosive reflux disease (ERD), 17 severe ERD, 25 nonerosive reflux disease (NERD), 15 reflux hypersensitivity (RH), and 19 functional heartburn (FH). A total of 100 length measurements were performed for each patient’s biopsy. Results The overall intercellular spaces (ISs) value of gastroesophageal reflux disease (GERD) patients was higher than that of HC (P = 0.020). In phenotypes, mild ERD (vs HC [P = 0.036], NERD [P = 0.004], RH [P = 0.014]) and severe ERD (vs HC [P = 0.002], NERD [P < 0.001], RH [P = 0.001], FH [P = 0.004]) showed significantly higher IS. There was no significant difference between the HC, NERD, RH, and FH groups. The 1.12 μm DIS cutoff value had 63.5% sensitivity and 66.7% specificity in the diagnosis of GERD. There was a weak correlation (r = 0.302) between the IS value and acid exposure time, and a weak correlation (r = −0.359) between the IS value and baseline impedance. A strong correlation was shown between acid exposure time and baseline impedance (r = −0.783). Conclusions Since the IS length measurement had better discrimination power only in erosive groups, it is not feasible to use in daily routine to discriminate other nonerosive phenotypes and FH. The role of DIS in heartburn in nonerosive patients should be reconsidered.
- 1 April 2023
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 21 (1) , 60-68
Clinical Features, Prognostic Factors and Outcome of Children with Ewing Sarcoma: A Single-center Experience
- 1 April 2023
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 21 (1) , 60-68
Clinical Features, Prognostic Factors and Outcome of Children with Ewing Sarcoma: A Single-center Experience
- Open Access
- 1 January 2023
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 14 (Suppl_01) , S86-89
Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer
- 1 January 2023
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 14 (Suppl_01) , S86-89
Open AccessEpidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer
- 11 January 2022
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (3) , 129-135
Endoskopik incelemede saptanan mide poliplerinin yerleşimi, histopatolojik tipleri ve tedavi yönetimi
Giriş ve Amaç: Gastrik polip lümene doğru çıkıntı oluşturan, mukoza veya submukozadan köken alan sesil ya da saplı lezyonlar olarak tanımlanır. Bu çalışmanın amacı, gastroskopi işlemi sırasında tespit edilen poliplerin görülme sıklığının, gastrik polip saptanan hastaların demografik özelliklerinin, poliplerin endoskopik ve histopatolojik özelliklerinin, eşlik eden diğer endoskopik bulguların ve tedavi şekillerinin değerlendirilmesidir. Gereç ve Yöntem: Bu çalışmaya, Haziran 2017 ile Haziran 2020 tarihleri arasında üniversite hastanemiz gastroenteroloji bölümü endoskopi ünitesinde yapılan 13280 gastroskopi işleminde, polip saptanan 80 hasta dahil edildi. Seksen hastada toplam 125 polip saptandı ve retrospektif olarak değerlendirildi. Hastaların yaşı ve cinsiyeti, gastroskopi yapılma nedeni, polip sayısı, poliplerin midedeki lokalizasyonu, polipektomi yöntemi, polip histopatolojisi, Helicobacter pylori pozitifliği, intestinal metaplazi varlığı, atrofik gastrit varlığı, polipektomi sonrası komplikasyon gelişip gelişmediği tarandı. Bulgular: Seksen (%0.6) hasta ve bu hastalarda saptanan toplam 125 polip sonucu değerlendirildi. Hastaların 54’ü (%67.5) kadın ve yaş ortalaması 57.5 ± 12.5 yıldı. Hastaların %51.2’sinde endoskopi yapılma nedeni, başka merkezlerden kliniğimize polipektomi amacıyla yönlendirilmeleriydi. Mide mukoza örneklemesinde hastaların %11.3’ünde Helicobacter pylori pozitifliği, %20’sinde intestinal metaplazi, %21.2’sinde atrofik gastrit mevcuttu. Poliplerin %65.6’sında polip boyutu 10 mm’nin altındaydı. Polipler sırasıyla; en sık korpusta (%54.4), antrumda (%22.4) ve fundusta (%20.8) saptandı. Poliplerin histopatolojisi en sık fundik gland polip (%42.4), hiperplastik polip (%30.4) ve nöroendokrin tümördü (%20.8). En sık uygulanan polipektomi yöntemi poliplerin %51.2’sinde biyopsi forsepsi ile polipektomidir. Hastaların 5’inde (%4) polipektomi komplikasyonu olarak postpolipektomi interprosedürel kanama gelişti. Sonuç: Çalışmamızda mide polip saptanma oranı literatür ile uyumlu bulunmuştur. Endoskopik olarak bazen poliplerin birbirinden ayırt edilmesi zor olabildiğinden mümkün olan her polibe güvenli bir şekilde polipektomi yapılmalı ve komşu mide mukozasından örnekler alınmalıdır.
- 11 January 2022
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (3) , 129-135
Endoskopik incelemede saptanan mide poliplerinin yerleşimi, histopatolojik tipleri ve tedavi yönetimi
Giriş ve Amaç: Gastrik polip lümene doğru çıkıntı oluşturan, mukoza veya submukozadan köken alan sesil ya da saplı lezyonlar olarak tanımlanır. Bu çalışmanın amacı, gastroskopi işlemi sırasında tespit edilen poliplerin görülme sıklığının, gastrik polip saptanan hastaların demografik özelliklerinin, poliplerin endoskopik ve histopatolojik özelliklerinin, eşlik eden diğer endoskopik bulguların ve tedavi şekillerinin değerlendirilmesidir. Gereç ve Yöntem: Bu çalışmaya, Haziran 2017 ile Haziran 2020 tarihleri arasında üniversite hastanemiz gastroenteroloji bölümü endoskopi ünitesinde yapılan 13280 gastroskopi işleminde, polip saptanan 80 hasta dahil edildi. Seksen hastada toplam 125 polip saptandı ve retrospektif olarak değerlendirildi. Hastaların yaşı ve cinsiyeti, gastroskopi yapılma nedeni, polip sayısı, poliplerin midedeki lokalizasyonu, polipektomi yöntemi, polip histopatolojisi, Helicobacter pylori pozitifliği, intestinal metaplazi varlığı, atrofik gastrit varlığı, polipektomi sonrası komplikasyon gelişip gelişmediği tarandı. Bulgular: Seksen (%0.6) hasta ve bu hastalarda saptanan toplam 125 polip sonucu değerlendirildi. Hastaların 54’ü (%67.5) kadın ve yaş ortalaması 57.5 ± 12.5 yıldı. Hastaların %51.2’sinde endoskopi yapılma nedeni, başka merkezlerden kliniğimize polipektomi amacıyla yönlendirilmeleriydi. Mide mukoza örneklemesinde hastaların %11.3’ünde Helicobacter pylori pozitifliği, %20’sinde intestinal metaplazi, %21.2’sinde atrofik gastrit mevcuttu. Poliplerin %65.6’sında polip boyutu 10 mm’nin altındaydı. Polipler sırasıyla; en sık korpusta (%54.4), antrumda (%22.4) ve fundusta (%20.8) saptandı. Poliplerin histopatolojisi en sık fundik gland polip (%42.4), hiperplastik polip (%30.4) ve nöroendokrin tümördü (%20.8). En sık uygulanan polipektomi yöntemi poliplerin %51.2’sinde biyopsi forsepsi ile polipektomidir. Hastaların 5’inde (%4) polipektomi komplikasyonu olarak postpolipektomi interprosedürel kanama gelişti. Sonuç: Çalışmamızda mide polip saptanma oranı literatür ile uyumlu bulunmuştur. Endoskopik olarak bazen poliplerin birbirinden ayırt edilmesi zor olabildiğinden mümkün olan her polibe güvenli bir şekilde polipektomi yapılmalı ve komşu mide mukozasından örnekler alınmalıdır.
- 1 January 2022
- Published by Kare Publishing in Diagnostic and Interventional Endoscopy
- Vol. 1 (2) , 48-52
Small Bowel Involvement of Waldenstrom Macroglobulinemia: A Case Report
There is rare information in the literature regarding direct small bowel involvement of Waldenstrom macroglobulinemia. A 52-year-old male was admitted to the hospital with complaints of spleen mass and diarrhea and was diagnosed with lymphoma after splenectomy. In the upper gastrointestinal system, endoscopy performed due to watery diarrhea 8-10 times a day, no pathological findings were detected in the esophagus and stomach, but white nodular formations 1-2 mm in diameter were observed, covering almost the entire mucosa, combined with each other and continuous in the bulbus, second and third parts of duodenum. In the sample taken from the duodenum, it was noted that some of these deposits were located inside the lymphatics. In the histochemical examination, it was observed that the deposits were not stained with Congo red, they were stained red with Masson’s trichrome, and in the immunohistochemical examination, lambda and immunoglobulin M were positive and immunoglobulin G, immunoglobulin A, and kappa were negative. In ileocolonoscopy, the cecum was normal, the same lesions in the duodenum were observed in the terminal ileum, and the biopsy result was also reported as immunoglobulin M lambda deposits in the epithelium. The case was evaluated as small bowel involvement of Waldenstrom macroglobulinemia.
- 1 January 2022
- Published by Kare Publishing in Diagnostic and Interventional Endoscopy
- Vol. 1 (2) , 48-52
Small Bowel Involvement of Waldenstrom Macroglobulinemia: A Case Report
There is rare information in the literature regarding direct small bowel involvement of Waldenstrom macroglobulinemia. A 52-year-old male was admitted to the hospital with complaints of spleen mass and diarrhea and was diagnosed with lymphoma after splenectomy. In the upper gastrointestinal system, endoscopy performed due to watery diarrhea 8-10 times a day, no pathological findings were detected in the esophagus and stomach, but white nodular formations 1-2 mm in diameter were observed, covering almost the entire mucosa, combined with each other and continuous in the bulbus, second and third parts of duodenum. In the sample taken from the duodenum, it was noted that some of these deposits were located inside the lymphatics. In the histochemical examination, it was observed that the deposits were not stained with Congo red, they were stained red with Masson’s trichrome, and in the immunohistochemical examination, lambda and immunoglobulin M were positive and immunoglobulin G, immunoglobulin A, and kappa were negative. In ileocolonoscopy, the cecum was normal, the same lesions in the duodenum were observed in the terminal ileum, and the biopsy result was also reported as immunoglobulin M lambda deposits in the epithelium. The case was evaluated as small bowel involvement of Waldenstrom macroglobulinemia.